C07D

Technology

Watch 707Status Updates

Stats

Description

HETEROCYCLIC COMPOUNDS

Subclasses

SubclassTitle
201/00 Preparation, separation, purification, or stabilisation of unsubstituted lactams
201/02 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams
201/04 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement
201/06 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement from ketones by simultaneous oxime formation and rearrangement
201/08 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from carboxylic acids or derivatives thereof, e.g. hydroxy carboxylic acids, lactones, nitriles
201/10 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from cycloaliphatic compounds by simultaneous nitrosylation and rearrangement
201/12 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams by depolymerising polyamides
201/14 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of salts or adducts of lactams
201/16 Preparation, separation, purification, or stabilisation of unsubstituted lactams Separation or purification
201/18 Preparation, separation, purification, or stabilisation of unsubstituted lactams Stabilisation
203/00 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
203/02 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom Preparation by ring-closure
203/04 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
203/06 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
203/08 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
203/10 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom Radicals substituted by singly bound oxygen atoms
203/12 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom Radicals substituted by nitrogen atoms not forming part of a nitro radical
203/14 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
203/16 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
203/18 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof

more results

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
RE49948 Aryl ethers and uses thereofFeb 03, 22Apr 30, 24Peloton Therapeutics, Inc.
RE49931 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsJan 25, 22Apr 23, 24Bristol-Myers Squibb Company
RE49934 Inhibitors of cellular metabolic processesMar 08, 22Apr 23, 24Servier Pharmaceuticals LLC
RE49918 Cytotoxic benzodiazepine derivativesMay 10, 21Apr 16, 24Immunogen Inc.

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2024/0148,690 COMPOSITIONS COMPRISING UROLITHIN COMPOUNDSJan 19, 24May 09, 24Not available
2024/0148,694 TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMSDec 12, 23May 09, 24Eli Lilly and Company
2024/0148,699 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITIONJan 05, 24May 09, 24Otsuka Pharmaceutical Co. Ltd.
2024/0148,721 DISCRETE PEG CONSTRUCTSDec 11, 23May 09, 24Not available
2024/0148,722 SMALL MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF ALS AND RELATED DISORDERSFeb 20, 22May 09, 24Not available
2024/0148,727 OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVEJan 12, 24May 09, 24Dainippon Sumitomo Pharma Co. Ltd.
2024/0148,732 TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERSJan 25, 22May 09, 24Not available
2024/0148,742 METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOFDec 22, 23May 09, 24Not available
2024/0148,744 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASESFeb 08, 22May 09, 24Not available
2024/0148,916 BIVALENT FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONSFeb 11, 22May 09, 24Not available
2024/0152,048 RADIATION-SENSITIVE RESIN COMPOSITION AND PATTERN FORMATION METHODDec 20, 21May 09, 24JSR Corporation
2024/0151,663 SELECTION METHOD FOR CONDITIONS TO INTRODUCE A GUEST ANALYTE COMPOUND INTO CRYSTALLINE POLYNUCLEAR METAL COMPLEX FOR USE OF SUCH CRYSTALLINE POLYNUCLEAR METAL COMPLEX INCLUDING A GUEST COMPOUND ANALYTE IN A METHOD FOR DETERMINING MOLECULAR STRUCTURE OF THE GUEST COMPOUND ANALYTEFeb 15, 22May 09, 24Not available
2024/0150,284 Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses ThereofOct 12, 23May 09, 24Sanofi
2024/0150,288 ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASEApr 27, 23May 09, 24Cognition Therapeutics, Inc.
2024/0150,292 METHOD FOR PRODUCING AMINO ACID DERIVATIVESDec 20, 23May 09, 24API CORPORATION
2024/0150,296 HUMAN PLASMA KALLIKREIN INHIBITORSApr 18, 23May 09, 24Not available
2024/0150,300 S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOFFeb 18, 22May 09, 24Not available
2024/0150,304 FORMULATION OF METAXALONEJul 12, 23May 09, 24Not available
2024/0150,308 PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF BENZOPROSTACYCLIN ANALOGUES AND BENZOPROSTACYCLIN ANALOGUES PREPARED THEREFROMDec 07, 23May 09, 24CHIROGATE INTERNATIONAL INC.
2024/0150,312 PYRAZINE COMPOUNDDec 07, 23May 09, 24Not available

more results

Top Owners in This Class

Upgrade to the Professional Level to view Top Owners for this Class.Learn More

Applications Filed in This Class - By Year

Patents Issued To Date - By Filing Year

Average Time to Issuance